Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefazolin vs Combinations in PPROM
NCT01401179Phase 3Completed
- Sponsor
- Samsung Medical Center
- Start
- Apr 2005
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of erythromycin, clarithromycin in Preterm Premature Rupture of Membranes (PPROM), sponsored by Samsung Medical Center. Started Apr 2005; status: completed.
02
Drugs
erythromycinclarithromycin
03
Conditions
Preterm Premature Rupture of Membranes (PPROM)
Beyond the preview
Go deeper on NCT01401179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01401179.